🇺🇸 FDA
Patent

US 11834441

Substituted tetrahydrofurans as modulators of sodium channels

granted A61PA61P29/00

Quick answer

US patent 11834441 (Substituted tetrahydrofurans as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61P, A61P29/00